JASPAC-01 study results - Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for resected pancreatic cancer patients
Dr. Jordan Berlin talks about the JASPAC-01 study results (Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for resected pancreatic cancer patients) at ASCO GI 2013
Author: imedex
Added: 02/02/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Chemotherapy | Middle East Health | Pancreas | Pancreatic Cancer | Study